Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism. [PDF]
Gatto F+11 more
europepmc +1 more source
L-Dopa Might Be Insufficient to Suppress Development of Prolactinomas in Dihydropteridine Reductase-Deficiency Patients. [PDF]
Diaz-Moreno U+4 more
europepmc +1 more source
Budget impact analysis of cabergoline for medical treatment of Cushing's disease in Brazil. [PDF]
Silva LFO+3 more
europepmc +1 more source
MicroRNA networks in prolactinoma tumorigenesis: a scoping review. [PDF]
Rad SG, Orang FN, Shadbad MA.
europepmc +1 more source
Double pituitary adenoma associated with acromegaly and hyperprolactinemia: a case report. [PDF]
Falcone MGG+5 more
europepmc +1 more source
Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report. [PDF]
Kubo H+8 more
europepmc +1 more source
Ergot alkaloid control in biotechnological processes and pharmaceuticals (a mini review). [PDF]
Volnin A+4 more
europepmc +1 more source
Investigating the relationship between cognitive impairment and brain white matter tracts using diffusion tensor imaging in patients with prolactinoma. [PDF]
Duru M+9 more
europepmc +1 more source